Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

ABIVAX SA

AAVXFPNK
Healthcare
Biotechnology
$115.65
$0.00(0.00%)
U.S. Market opens in 55h 11m

ABIVAX SA (AAVXF) Stock Overview

Explore ABIVAX SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9.1B
P/E Ratio-32.48
EPS (TTM)$-5.23
ROE50.78%
Fundamental Analysis

AI Price Forecasts

1 Month$123.99
3 Months$102.81
1 Year Target$55.88

AAVXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ABIVAX SA (AAVXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 33.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $55.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -32.48 and a market capitalization of 9.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.96%
5-Day Change
N/A
1-Month Change
-7.97%
3-Month Change
-2.69%
6-Month Change
34.32%
Year-to-Date (YTD) Change
-2.69%
1-Year Change
1573.66%
3-Year Change
1573.66%
5-Year Change
384.91%
All-Time (Max) Change
1208.26%

Contact Information

33 1 53 83 08 41
5, rue de la Baume, Paris, NaN, 75008

Company Facts

690 Employees
IPO DateSep 27, 2016
CountryFR
Actively Trading

Frequently Asked Questions